Biogen Defends Newly Approved Alzheimer’s Drug
Biogen Defends Newly Approved Alzheimer’s Drug
The US Food and Drug Administration has called for a federal investigation of its own regulatory review process after widespread criticism of its decision on Aduhelm.
Biogen Defends Newly Approved Alzheimer’s Drug
Biogen Defends Newly Approved Alzheimer’s Drug

The US Food and Drug Administration has called for a federal investigation of its own regulatory review process after widespread criticism of its decision on Aduhelm.

The US Food and Drug Administration has called for a federal investigation of its own regulatory review process after widespread criticism of its decision on Aduhelm.

neurodegenerative diseases
Harnessing Stem Cells to Model Neurological Disorders
Harnessing Stem Cells to Model Neurological Disorders
The Scientist Creative Services Team | Apr 15, 2021
Biomarker Discovery with SMC<sup>TM</sup> Technology
Biomarker Discovery with SMCTM Technology
The Scientist Creative Services Team | Apr 6, 2021
Single Molecule Counting (SMC™) technology offers the sensitivity to reveal hidden biomarker information
Questions Raised About Widely Used Blood-Brain Barrier Model
Questions Raised About Widely Used Blood-Brain Barrier Model
Catherine Offord | Feb 16, 2021
A study has sparked controversy by suggesting that cells made using a popular lab protocol have been misidentified, with potentially serious repercussions for brain research. Critics say the significance of the findings has been overstated.
First Alzheimer&rsquo;s Blood Test Rolled Out for Clinical Use in US
First Alzheimer’s Blood Test Rolled Out for Clinical Use in US
Shawna Williams | Nov 2, 2020
The test will be a cheaper and more accessible alternative to currently available diagnostic tools, researchers say.
The Scientist&#39;s LabTalk Podcast - Episode 2
The Scientist's LabTalk Podcast - Episode 2
The Scientist Creative Services Team | Oct 20, 2020
Surviving Stress: The mysteries of neuronal survival and neurodegeneration
Breaking Down Barriers
Breaking Down Barriers
The Scientist Creative Services Team | Oct 19, 2020
Looking at the future of neurodegeneration research!
Advancing Disease Research with Mass Spectrometry
Advancing Disease Research with Mass Spectrometry
The Scientist Creative Services Team | Sep 15, 2020
Explore just how indispensible mass spectrometry is becoming to life science researchers.
New Drug Combo for ALS Slows Decline in Small Clinical Study
New Drug Combo for ALS Slows Decline in Small Clinical Study
Jef Akst | Sep 3, 2020
After six months, patients with fast-progressing amyotrophic lateral sclerosis who had received the experimental treatment had less loss of function than those who received a placebo.
Flu and Pneumonia Vaccines Linked to Reduced Risk of Alzheimer&rsquo;s
Flu and Pneumonia Vaccines Linked to Reduced Risk of Alzheimer’s
Amanda Heidt | Jul 27, 2020
The authors propose that the shots might keep the immune system primed to battle diseases that would otherwise contribute to cognitive decline.
Astrocyte-to-Neuron Method Reverses Neurodegeneration in Mice
Astrocyte-to-Neuron Method Reverses Neurodegeneration in Mice
Ruth Williams | Jun 24, 2020
The cell conversion strategy restores neurons and motor functions lost as a result of an induced Parkinson’s-like illness in the animals.
Variants in Water Channel Gene Tied to More Restful Sleep
Variants in Water Channel Gene Tied to More Restful Sleep
Abby Olena | May 12, 2020
The gene, aquaporin-4, is critical in rodents for the cerebrospinal fluid bath the brain gets during sleep. It’s now also tied to slow wave electrical activity during deep sleep in people.
<em>The Scientist&nbsp;</em>Infographics: Editor&rsquo;s Picks of 2019
The Scientist Infographics: Editor’s Picks of 2019
Jef Akst | Dec 18, 2019
This year’s most beautiful illustrations covered topics including the molecular underpinnings of Parkinson’s disease and strategies for tracking marine organisms around the world’s oceans.
Interactive: Biomarkers in Blood Provide a Window into the Brain
Interactive: Biomarkers in Blood Provide a Window into the Brain
Shawna Williams | Dec 1, 2019
A look at some of the circulating molecules that may indicate various Alzheimer’s pathologies and serve as the bases of noninvasive tests for the disease.
The Hunt for a Blood Test for Alzheimer&rsquo;s Disease
The Hunt for a Blood Test for Alzheimer’s Disease
Shawna Williams | Dec 1, 2019
Researchers hope circulating biomarkers will enable earlier detection and better monitoring of the neurodegenerative disorder—and perhaps help usher in new treatments.
Is It Time to Rethink Parkinson&rsquo;s Pathology?
Is It Time to Rethink Parkinson’s Pathology?
Ashley Yeager | Oct 1, 2019
New evidence points to a waste-clearing problem in patients’ cells, rather than the accumulation of protein tangles, as the root cause of the neurodegenerative disease.
Infographic: How Air Pollution Could Affect the Brain
Infographic: How Air Pollution Could Affect the Brain
Catherine Offord | Oct 1, 2019
Evidence is accumulating that breathing contaminated air might impair cognition.
Air Pollution May Damage People&rsquo;s Brains
Air Pollution May Damage People’s Brains
Catherine Offord | Oct 1, 2019
Contaminants in the atmosphere appear to have harmful effects on neurodevelopment and cognitive function.
Genetic Risk for Alzheimer&rsquo;s Disease Linked to Highly Active Brains
Genetic Risk for Alzheimer’s Disease Linked to Highly Active Brains
Diana Kwon | Oct 1, 2019
A growing body of evidence supports the theory that neural hyperactivity and hyperconnectivity precede the pathological changes that lead to neurodegeneration.
Could Brain Activity During Sleep Be a Biomarker for Alzheimer&rsquo;s?
Could Brain Activity During Sleep Be a Biomarker for Alzheimer’s?
Ashley Yeager | Oct 1, 2019
Changes in brain waves while snoozing correlate with accumulation of tau and amyloid-β, suggesting that the neural activity disruptions could clue doctors in to early development of the disease.